Pfizer publish series of MEK inhibitors « Kinase News

Blogroll
Tags

AstraZeneca aurora Avastin bayer Bcr-Abl bevacizumab BMS c-kit cetuximab EGFR ErbB-2 ErbB2 erbitux Exelixis Genentech GlaxoSmithKline Gleevec GSK HER1 HER2 IGF-1R Imatinib ImClone JAK2 kinase Merck-Serono Met mTOR multikinase Nexavar Novartis onyx PDGF Pfizer phase I Phase II phase iii PI3K Preclinical regulatory Research Roche sorafenib VEGF VEGFR2
Providing a resource for information on kinase inhibitors

Pfizer publish series of MEK inhibitors

Posted on October 7, 2008 by crimsoncanary

Pfizer have publsihed a series of MEK (MAP ERK Kinase) inhibitors.

Filed under: Uncategorized | Tagged: kinase, MEK, Pfizer, Preclinical, Research

« Vertex publish series of Syk kinase inhibitors Oncalis license PI3K inhibitors from ChemDiv »